Is Puma Biotechnology (PBYI) Stock Undervalued Right Now? - Yahoo Finance
Yesterday • Google News
Puma Biotechnology Inc (PBYI)
US$ 3.044.47%
Price Chart
Key Statistics
Market Cap
$ 165.29M
P/E Ratio
4.27
Revenue (TTM)
$ 232.71M
Volume
432.84K
52W High
$ 4.13
52W Low
$ 2.23
Dividend Yield
0.00%
Beta
1.28
Technicals
50-Day MA
3.2526
200-Day MA
3.0327
52 Week High
4.13
52 Week Low
2.225
About PBYI
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
Employees
172
Headquarters
Los Angeles, CA
CEO
Mr. Alan H. Auerbach
Latest News
Fast-paced Momentum Stock Puma Biotech (PBYI) Is Still Trading at a Bargain - Nasdaq
4 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg